Cowen Cuts Price Target on Solazyme (SZYM) Following Earnings Results
Cowen maintained a Market Perform rating on Solazyme (NASDAQ: SZYM), and cut the price target to $3.25 (from $4.00), following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
